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Novelty statement: 
 Knowledge on the prevalence of diabetes among older persons receiving care at home 
is scarce. 
 The prevalence of diabetes was 24%, and among those with diabetes, 14% were 
unaware of their diagnosis, and reported significantly poorer health status than those 
with known diabetes. 
 Diabetes deserves increased case-finding efforts and allocation of resources to 
alleviate symptoms and burden of inadequate diabetes care at home. 
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Abstract (250 word) 
Aims. To determine the prevalence of diabetes among older people receiving care at home, 
and to explore differences in sociodemographic and clinical characteristics, symptoms, health 
status, quality of life and psychological well-being between different diabetes categories 
defined by glycated haemoglobin (HbA1c) ≥ 48 mmol/mol [6.5%] and/or self-report. 
Methods. A community-based sample of 377 persons receiving care at home in Western 
Norway participated in a cross-sectional survey. Instruments included the MMSE-NR, 
Symptom Check-List, WHO Quality of Life-BREF (WHOQOL-BREF, two global items), 
EuroQol EQ-5D-5L/ EQ-5D-VAS, and WHO-Five Well-Being Index (WHO-5). Participants 
were grouped into four categories: no diabetes, only self-report, HbA1c ≥ 48 mmol/mol 
[6.5%] and self-report, and only HbA1c ≥ 48 mmol/mol [6.5%].  
Results. Median age (interquartile range) was 86 (81-91) years and 34% were men. We 
identified 92 participants (24%) with diabetes. Diabetes was more prevalent in men compared 
to women (34% vs 20%, age-adjusted p=0.005). Among persons with diabetes, 14% were 
unaware of their diagnosis. There were significant differences in symptoms between the 
diabetes categories, with more symptoms (abnormal thirst, polyuria, genital itching, nausea, 
excessive hunger, perspiring, cold hands/feet, daytime sleepiness) among the groups with 
elevated HbA1c. Significant differences in WHO-5, WHOQOL-BREF and EQ-5D-5L 
between diabetes categories were identified, with poorest scores in the group with 
undiagnosed diabetes. 
Conclusions. There is a high percentage of older people with diabetes receiving care at home 
who are unaware of their diagnosis. Diabetes deserves increased case-finding efforts and 
allocation of resources to alleviate symptoms and burden of inadequate diabetes care towards 
those receiving care at home. 





The prevalence of blood glucose lowering drug use increases with age (1), and both older age 
and diabetes increase the risk of disabilities (2). In Norway, the peak prevalence of blood 
glucose-lowering drug use in men is at age 76 years (12.4%) and in women at age 80 years 
(9.9%) (1).  
 Alterations in the health care system and in epidemiological patterns will presumably 
increase the number of people with diabetes receiving care at home, but knowledge of the 
prevalence of diabetes in such care is scarce. Internationally, the reported prevalence of 
diabetes among those receiving care at home has been estimated to be 27% in a US study and 
30.6% in Germany (3, 4). In Norway, Jorde and Hagen (5) estimated the combined prevalence 
of diabetes amongst persons receiving care at home and in nursing homes to be 20.2%. Given 
the trend of rapid increase of number of people with diabetes worldwide, and diabetes as the 
leading cause of death and disability, further studies are needed to determine the prevalence of 
diabetes in populations that include very old people.  
The ultimate goals for home care services are to maintain quality of life and functional 
status and to replace expensive hospital care and nursing homes with care delivered in the 
persons’ home (6). However, home care service staff do not always have information about 
the patient’s diagnoses and vital clinical information (7). Older people with diabetes are often 
characterized by progressive cognitive and functional decline (8) and poor psychological 
well-being (2, 9), all negatively influencing diabetes management. Older people with diabetes 
are at increased risk of urinary incontinence, cognitive and behavioural disturbances as well 
as falls due to hypoglycaemia episodes (10). Thus, diagnosed or undiagnosed, older people 
with diabetes living at home may have symptoms of diabetes affecting their general health 
and psychological well-being.  
In order to manage their diabetes and compensate for higher risk of comorbidity and 
mortality, people with diabetes need closer follow-up and assistance compared to those 
without diabetes. One study in the US have already explored demographic and social 
characteristics of people with diabetes receiving care at home in the United States (11), as 
well as the individual’s perspective in terms of unmet care needs (12). However, to our 
knowledge there are no published studies in which diabetes prevalence among people 
receiving care at home have been studied alongside clinical and self-reported information in 
order to explore diabetes care in the home care services. Awareness regarding the prevalence 
of diabetes and the association between diabetes and psychological well-being is needed in 
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order to adjust resources and increase competence in home care services. Thus, our aims were 
to:  
 Determine the prevalence of diabetes, defined as glycated haemoglobin (HbA1c) ≥ 
48mmol/mol [6.5%] and/ or self-report, among older people receiving care at home.  
 Explore differences between diabetes categories (no diabetes, self-report only, HbA1c 
≥ 48mmol/mol [6.5%] and self-report, and only HbA1c ≥ 48mmol/mol [6.5%]) 
regarding sociodemographic and clinical characteristics, self-reported symptoms, 
health status, overall quality of life and psychological well-being.  
Participants and Methods  
Study population 
The study population was recruited among those receiving care at home, aged 65 years and 
older and living in the city of Bergen, Western Norway between May 2014 to March 2015. At 
the time of sample identification from the municipal electronic health records, this comprised 
3,666 persons. Based on a power calculation for a t-test comparing the mean World Health 
Organization’s Five Well-being index (WHO-5) between persons with and without diabetes 
with an allocation ratio of 1 to 5 and standard deviation 20, the required sample size was 
estimated to be 228 in order to detect a 10 point difference with 80% power and 5% 
significance level. Due to the frailty in this population, a previously reported low participation 
rate (30%) in a similar population sample (5), and in order to get sufficient statistical power to 
allow for adjustment for age and gender, 1,100 persons were randomly selected by stratified 
sampling according to the population size in each of the municipality’s 10 zones. Registered 
nurses with knowledge of the people screened each identified person. Exclusion criteria were 
terminal/palliative care or serious medical condition, transfer to permanent residency at a 
nursing home, no longer receiving care at home after the random selection or severe cognitive 
impairment (The Norwegian Revised Mini Mental State Examination, MMSE-NR < 9). In 
addition, 113 persons died between the time of sampling and start of the study. In total, 677 
persons were found eligible for participation. See supplemental Figure 1 for flow diagram of 
recruitment and exclusions. After initial information by a home care services’ nurse, one of 
the three trained study nurses asked for consent and collected the data. With 298 persons 
declining participation and 2 excluded during or after data collection (1 with MMSE-NR<9 
and 1 withdrawal), 377 persons (55.7%) were finally included. Of these, four did not 
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complete the full questionnaire and were therefore excluded from some analyses (see Table 3 
and Table 4).  
 
Measures 
HbA1c was measured in a capillary blood sample, and a structured interview using a self-
reported questionnaire was conducted. The questionnaire was initially piloted on five persons, 
confirming the comprehensibility of the content and the feasibility of the procedure for data 
collection. All data were collected from May 2014 to March 2015 in the persons’ homes. 
 HbA1c was obtained by analysing capillary blood samples spectrophotometrically 
using a DCA Vantage TM Analyzer (Siemens Healthcare Diagnostics AS¸ Norway). Three 
machines with identical settings and reagent kits with identical batch and LOT numbers were 
used. To ensure precision and accuracy of the machines, both internal and external quality 
control tests were performed regularly throughout the data collection period. In accordance 
with the WHO recommendations (13),  HbA1c of 48 mmol/mol [6.5%] or higher was used as 
diagnostic criteria for diabetes. Although two measurements above the cut-off are usually 
recommended for a clinical diagnosis of diabetes in asymptomatic individuals, one such 
measurement is usually considered sufficient in epidemiological studies. Self-reported and 
unknown diabetes were identified by the question “do you have, or have you ever had, 
diabetes?” This question has shown satisfactory validity and reliability (14).  
The MMSE-NR, a 30-item questionnaire, revised and translated into Norwegian (15), 
was used to assess cognitive status. A score greater than or equal to 27 indicates normal 
cognition.  
The Symptom Check-List (TSCL), a 19-item questionnaire regarding symptoms such 
as headache, abnormal thirst and excessive urination was used to assess symptoms associated 
with diabetes. Respondents reported symptoms within the last week from 1 (never) to 5 (every 
day). The questionnaire has been translated and used in previous studies in Norway (16).  
Symptom score was calculated both as the total number of symptoms present the last week 
and as the mean of the 19 items. 
Two global items from the WHO Quality of Life-BREF (WHOQOL-BREF) (17); 
Overall quality of life and General health were used. Both are rated on a five point Likert 
scale with higher scores indicating better overall quality of life or general health. The 
questionnaire has been translated into Norwegian and has shown satisfactory psychometric 
properties (18).  
6 
 
The EuroQol EQ-5D-5L (19) was used to measure health status. The instrument 
consists of five items measuring general health status such as mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression, measured on a Likert scale from 1-5 with 
higher scores indicating more difficulties in task performance, and elevated pain or anxiety. 
The response to these five items jointly formed an overall health status, which was further 
translated into a EQ-5D-5L utility index value summarizing the health status from below zero 
(a condition worse than death), 0 (equivalent to death) and up to 1 (full health) (20). As per 
august 2016 there are EQ-5D-5L value sets available for seven countries, where value sets 
from England (20) were used due to the nearest proximity with Norway. EQ-5D also 
comprises a visual analogue scale (EQ-5D-VAS), measuring self-reported health status from 
1 (worst possible health) to 100 (best possible health) on the day of the survey.  
The WHO-Five Well-Being Index (WHO-5) was used to measure psychological well-
being (9) by means of five positively worded items reported on a six-point Likert scale 
ranging from 0 (not present) to 5 (constantly present). An overall score was calculated as the 
sum of the five items and rescaled to values ranging from 0 (worst thinkable well-being) to 
100 (best thinkable well-being). WHO-5 has been shown to be a psychometrically sound 
measure of well-being (21) and the construct validity has been evaluated as satisfactory (9).   
We measured internal consistency of multi-item questionnaires with Cronbach alpha 
coefficients for persons with and without diabetes; the coefficients were 0.72 and 0.68 for 
TSCL, 0.74 and 0.64 for WHO-5, 0.77 and 0.67 for EQ-5D-5-L, respectively. 
 
Ethical considerations 
The Regional Committee for Medical and Health Research Ethics approved the study 
(2013/2258/REK vest). Each individual was informed of the study, asked to give consent, and 
informed that they could withdraw their consent at any time. Confidentiality was assured by 
using identification numbers. In the case where an elevated HbA1c was identified, the 
information was sent to the person’s general practitioner. 
 
Statistical analyses  
Diabetes was defined as either self-reported diabetes or HbA1c ≥ 48 mmol/mol [6.5%]. 
Diabetes prevalence with 95% CI was estimated for the total sample, for men and women 
separately, and for 10-year age groups using an offset-only Generalized Linear Model (GLM) 
with identity link and binomial distribution. Differences in prevalence between men and 
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women were also tested for significance using GLM with gender as a covariate with 
adjustment for age.  
Descriptive statistics were used to compute frequencies and percentages for 
categorical variables and means and standard deviations (SD) for continuous variables. 
Comparisons between diabetes categories (no diabetes, HbA1c ≥ 48mmol/mol [6.5%] and 
self-report, only self-report and only HbA1c ≥ 48mmol/mol [6.5%]) were performed using 
Exact Fishers Chi squared test (categorical variables) and one way ANOVA (continuous 
variables).  Levene’s test for homogeneity of variance showed non-significant difference in 
variance between groups for all analyses. Inspection of normal Q-Q plots of standardized 
residuals showed small deviations from normality. To confirm the results from the ANOVA 
we therefore did a non-parametric Kruskal-Wallis test. The Kruskal-Wallis tests yielded the 
same conclusions as ANOVA and we have therefore only included the results for the 
ANOVA-analyses. We adjusted for age and sex using binary logistic or multinomial logistic 
regression (categorical variables) and ANCOVA (continuous variables). When testing the 19 
symptoms from the Symptom Check-List we corrected the obtained p-values for multiple 
testing using the Benjamini–Hochberg procedure (22).  All analyses were performed with 
SPSS software (Version 23; IBM Corp., Armonk, NY, USA) except for correction of p-values 
for multiple testing which was done using the multtest procedure in SAS version 9.4 (SAS 
Institute Inc., Cary, NC, USA). 
Results 
The median age (IQR) for the participants was 86 years (81-91) and 34% (n=127) were men. 
Information available to compare participants with those excluded and those who declined 
participation included age (85, 85 and 86 years, respectively; p=0.21) and gender distribution 
(men: 33.7%, 39.1% and 24.5%, respectively; p=< 0.001). Although gender distribution was 
significantly different between participants and non-participants, the percentage of men in the 
study sample and the total eligible sample (N= 1100) was not (33.7% versus 33.3%). Only 
one person was excluded due to an MMSE-NR score below 9. Mean MMSE-NR score in the 
total sample (N= 377) was 23.8 (4.4) with non-significant difference between people with and 
without diabetes (p=0.50).  
We identified 92 participants with diabetes (24% [95% CI: 20, 29]). Diabetes was 
more prevalent in men (34% [95% CI: 26, 42] compared to women (20% [95% CI: 15, 25]), 
(age adjusted p-value 0.005, not shown in tables). Especially for women, the prevalence of 
diabetes declined with age. Table 1. summarizes the prevalence according to gender and ten-
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year age groups. The number of diabetes cases identified by 1) only self-reported was n= 27, 
2) both self-reported diabetes and HbA1c ≥ 48mmol/mol [6.5%] was n= 52, and 3) only HbA1c 
≥ 48mmol/mol [6.5%] was n= 13. Among the 27 participants with only self-report, a diabetes 
diagnosis was verified in 23 when checking against medical records, leaving 4 who were not 
verified. Figure 1 shows the number of persons in five-year age groups by diabetes status.  
Sociodemographic and clinical characteristics are shown in Table 2, stratified by 
diabetes categories. We found that 21 of the 27 persons with self-reported diabetes and an 
HbA1c below 48mmol/mol [6.5 %] were pharmacologically treated for diabetes, of whom five 
were using insulin. Further, among the persons with diabetes, 14 % had elevated HbA1c 
without being aware of this diagnosis, with HbA1c ranging from 48-68 mmol/mol [6.5- 8.4 
%]. For the two groups with elevated HbA1c combined the values ranged from 48-107 
mmol/mol [6.5 -11.9 %] with 75 % below 64 mmol/mol [8%], and 40 % below 53 mmol/mol 
[7%]. 
 There were significant differences in self-reported diabetes-related symptoms between 
the diabetes categories, with the two groups with elevated HbA1c reporting the highest number 
of symptoms (Table 3). Pairwise comparisons for total number of symptoms and mean 
symptom score showed significant differences between the group without diabetes and the 
group with both self-reported diabetes and HbA1c ≥ 48mmol/mol [6.5%]   (Supplemental 
Table 1 and 2). 
Further, we found significant differences in psychological well-being (WHO-5), 
overall health perception (WHOQOL-BREF 1item) and health status (EQ-5D-5L index value) 
between diabetes categories (Table 4); those with undiagnosed diabetes reported lower 
psychological well-being, poorer overall health and health status compared to the other 
categories. Pairwise comparisons showed significant differences between the group with 
undiagnosed diabetes and all of the three other groups for EQ-5D, but not for the other 
outcomes (Supplementary tables 3-7). 
When collapsing all three groups with diabetes into one group and comparing this with 
the group without diabetes we found significantly higher number of symptoms (unadjusted 
p<0.001), higher mean symptom score (unadjusted p<0.001), poorer WHOQOL-Overall 
health (unadjusted p=0.03), poorer EQ-5D-5L (unadjusted p=0.03) and poorer WHOQOL- 
overall quality of life (unadjusted p=0.045) in the diabetes group. There were no significant 
differences between these two groups with regard to EQ VAS (unadjusted p=0.15) and 





The overall prevalence of diabetes among people receiving care at home was 24%. About 
42% of men age 76-85 years had diabetes, indicating an increased need for diabetes treatment 
resources. The overall prevalence is similar to the prevalence reported for those who received 
care at home and in residential care homes combined in Tromsø, Norway (5), and in Dresden, 
Germany (4). In contrast, Caffrey et.al (3) found a prevalence of 30.6%, exceeding the 95% 
CI found in our study. It is possible that the diabetes prevalence of 24% found in our study 
may be underestimated, as a high proportion of the persons excluded were frail. Because older 
people with diabetes have an increased risk of mortality compared to same-age persons 
without diabetes (23), the lower prevalence of diabetes in the oldest age group in our study 
could be due to survival bias. In addition, we found a higher prevalence of diabetes in men in 
our study population (in the age group 86-102 years the prevalence in men was 30% and in 
women 14%, Table 1). A possible explanation is that men with diabetes have an increased 
risk of late complications compared to women (24, 25) and herby are more prone to receive 
care at home earlier than women. Furthermore, women with diabetes have a significant higher 
excess mortality compared to men (26) and are thus perhaps underrepresented in higher age 
groups in the home care services. In the youngest age groups there were no participants with 
HbA1c ≤ 6.5% only (undiagnosed diabetes).  We believe that this is a chance finding due to 
the low number of participants in this age group. These are rather young people compared to 
the regular receivers of care at home. However, due to their poor health status one explanation 
might be that they receive care at home based on an extensive diagnostic examination and 
thus having been made aware of their diabetes.  
There are significant differences in the living situation between participants with and 
without diabetes. The proportion living alone is higher among persons without diabetes 
compared to persons with diabetes. This might be due to a selection mechanism through 
which persons with diabetes who live alone and have functional decline, to a larger extent get 
transferred to residential care homes. They do not have carers who can compensate for their 
decreasing ability to manage their diabetes (27). 
 We found that 14% of persons with diabetes were unaware that they had the diagnosis 
indicating the need for more intensive case-finding efforts (screening and referral for 
diagnosis). The proportion of diabetes-cases that was undiagnosed is considerably lower than 
what is estimated for the general population (1, 23). The fact that our study is based on a 
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population receiving health care service might explain this, as they are more likely to have 
been screened for diabetes. 
Compared to persons with known diabetes, a higher proportion of persons with 
undiagnosed diabetes reported symptoms related to hyperglycaemia such as abnormal thirst, 
genital itching and vertigo. These are all symptoms that may be avoided with appropriate 
diagnosis and treatment for diabetes.  As the symptom burden of diabetes may impair quality 
of life and functioning (28), it is important to uncover diabetes and thus prevent symptoms.  
In contrast to findings reported by Jørgensen et.al. (29), those with undiagnosed 
diabetes reported significantly poorer health status than those with known diabetes. The 
former group also reported poorer overall health and psychological well-being compared to 
the other diabetes categories, however this difference was not statistically significant. Total 
mean WHO-5 score for the group without diabetes and those with undiagnosed diabetes were 
62.5 and 48.9, respectively. This difference is considered clinically significant (9). Moreover, 
with a score under 50, those with undiagnosed diabetes are characterized as having poor well-
being, and further assessment for clinical depression might be indicated (9). Compared to 
results from The Diabetes Attitudes, Wishes and Needs second study (DAWN2) where a 
mean WHO-5 score of 58.0 (SD 23.4) were found, the group with HbA1c ≥ 48 mmol/mol 
[6.5%] and self-reported diabetes in our study showed similar results (57.9 [SD 22.9]).  
 
Clinical implications 
Preventing long-term complications in a population of older people may not be the primary 
priority in most of these elderly and care-needing people receiving care in their homes. 
Treatment and care should primarily focus on avoiding burdensome symptoms and promoting 
overall health and well-being. We argue that an increased focus on finding persons with 
undiagnosed diabetes receiving care at home for treatment and care is important. Moreover, 
allocation of more resources to alleviate symptoms and burden of inadequate diabetes care 
could prevent diabetes related symptoms and improve psychological well-being. Promoting 
high quality care calls for competent personnel, capable to implement reliable screening 
instruments and relevant risk assessment tools to better identify disease burden and long-term 
care needs. 
 
Strengths and limitations 
As far as we know, this is the first study examining the prevalence of previously known and 
unknown diabetes among people receiving care at home in Norway and assessing the impact 
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of diabetes on symptoms, health status, overall quality of life and psychological well-being. 
The random sampling from all ten municipality zones in Bergen increases the 
representativeness of the sample and the use of HbA1c values as diagnostic criteria ensures a 
valid definition of diabetes.  
Limitations of the study include the observational nature that precludes conclusions 
concerning causal relationships. Furthermore, we did not collect information on diabetes type, 
duration of diabetes, medications other than glucose lowering medications, other factors that 
could affect HbA1c (such as anaemia and other disturbances in erythropoiesis), medications 
that might influence glucose metabolism (e.g corticosteroids), vascular complications or 
comorbidity status and frailty. People receiving care at home will have a significant disease 
burden and long-term care needs which all counts when symptom burden and quality of life is 
measured. Given this, the severity of diabetes, measured by long-term complications would 
have given more details in describing the participants’ health status. 
 Mean MMSE-NR score in the sample was low, at 23.8, and as cut-offs of 23/24 have 
been used to indicate cognitive impairment (30), one could question the reliability of the 
questionnaires in the present study. However, MMSE-NR is a measure of cognitive function, 
not a diagnostic test, and a score below 24 merely indicates that further testing should be 
performed. Only 4% of the study population had MMSE<15. A low score may also be due to 
loss of hearing, poor eyesight or other factors (15). Other limitations are that almost half of 
our researched population were excluded because of terminal/palliative care or serious 
medical condition, transfer to permanent residency at a nursing home, dead or no longer 
receiving care at home after the sampling. The exclusion of these persons from the final study 
population may have caused an underestimation of the prevalence of diabetes. The study was 
originally powered to compare only two groups: Those with diabetes versus those without. 
Since we have further divided the diabetes group into three categories the sample size for 
some groups are small, especially the group with high Hba1c and no self-report (n=13). The 
study therefore does not have sufficient statistical power to detect differences between this 
and the other groups, especially for single symptoms in Table 4 where the number of events 
are very low for some of the symptoms. Finally, the number of comparisons done in the 
analyses is high and this may have resulted in some chance findings. We have adjusted for 
multiple testing in the post-hoc tests after ANOVA and also when comparing multiple 
symptoms between groups, but there is still a risk of Type I error, especially for tests with p-
values close to 0.05. 
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 In conclusion, we found that having diabetes, either diagnosed or undiagnosed, was 
associated with more symptoms and poorer health status in this community-based study of 
people receiving care at home. The prevalence of diabetes was high, 24%, and 14% of those 
classified as having diabetes were previously undiagnosed. Diabetes constitutes a large 
burden of disease among those receiving care at home and deserves increased case-finding 
efforts and allocation of resources to alleviate symptoms and burden of inadequate diabetes 
care in people receiving care at home.  
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Table 1: Prevalence of diabetes (self-reported and/ or HbA1c ≥ 48 mmol/mol [6.5%] by gender and ten year age groups 
 Total Age group (years) 
  66-75 76-85 
 
86-102 















 (95% CI) 
Total 92*/377 24 (20 to 29) 15/49 31 (18 to 44) 40/133 30 (22 to 38) 37/195 19 (14 to 25) 
Men 43/127 34 (26 to 42) 5/21 24 (6 to 42) 21/50 42 (29 to 56) 17/56 30 (18 to 42) 
Women 49/250 20 (15 to 25) 10/28 36 (18 to 54) 19/83 23 (14 to 32 20/139 14 (9 to 20) 
Proportions and confidence intervals are estimated using an offset-only Generalized Linear Model with identity link and binomial distribution. 
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n 285 27 52 13   
  Age, Mean (SD) 86 (7) 83 (9) 83 (7) 87 (7) 0.03 0.06 
  Age, median (IQR***) 86 (81-91) 82 (75-91) 84 (79-88) 86 (81-93)   
  Gender, n (%)                    
    Men 84 (30) 10 (37) 28 (54) 5 (39)   
    Women 201 (71) 17 (63) 24 (46) 8 (62) 0.01 0.02 
  Living situation, n (%)       
    Living alone 240 (84) 19 (70) 29 (56) 9 (69)   
    Living with others 45 (16) 8 (30) 23 (44) 4 (31) <0.001 0.002 
  Education, n (%)       
    Primary school 160 (56) 20 (74) 28 (55) 2 (15)   
    High school 78 (27) 4 (15) 14 (27) 4 (31)   
    ≥ 4 years higher    education 47 (17) 3 (11) 9 (18) 7 (54) 0.01 0.004 
  HbA1c, mean (SD)        
    mmol/mol  38 (4) 42 (3) 61 (14) 52 (6) NA**** NA 
    % 5.6 (0.3) 6.0 (0.3) 7.7 (1.3) 6.9 (0.6) NA NA 
  Using insulin, n (%)  5 (19) 26 (50)  0.007 0.008 
  Using non-insulin   
  diabetes medications, n(%) 
 16 (68) 34 (64)  0.80 0.73 
  Non-pharmacological     
  Treatment/ Diet only, n(%) 
 9 (33) 7 (13)  0.07 0.04 
All reported percentages are column percentages. Four persons had missing values on the question about non-insulin medication and percentages are calculated among those 
who had valid values. *Oneway-ANOVA for continuous variables and exact Fishers Chi squared test for categorical variables ** Adjusted for age and sex (where applicable) 
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using logistic regression for all outcomes except for education where multinomial logistic regression was used and for age where ANCOVA was used. ***IQR=interquartile 
range. ****NA=Not applicable.  
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n 282 27 51 13   
Symptomsb, n (%)       
Headache 63 (22) 7 (26) 19 (37) 4 (31) 0.22 0.27 
Urinating at night  144 (51) 15 (56) 36 (71) 7 (54) 0.16 0.13 
Abnormal thirst 49 (17) 6 (22) 19 (37) 6 (46) 0.01 0.02 
Blurry vision 84 (30) 5 (19) 22 (43) 5 (39) 0.19 0.18 
Polyuria, daytime 57 (20) 12 (44) 23 (45) 3 (23) <0.001 <0.001 
Palpitation 39 (14) 3 (11) 12 (24) 2 (15) 0.38 0.39 
Genital itching  28 (9.9) 5 (19) 11 (22) 4 (31) 0.05 0.06 
Nausea 32 (11) 5 (19) 15 (29) 4 (31) 0.02 0.02 
Vertigo 119 (42) 9 (33) 22 (43) 8 (62) 0.46 0.45 
Vomiting 6 (2.1) 0 (0) 1 (2.0) 0 (0)   
Exhausted 107 (38) 15 (56) 24 (47) 6 (46) 0.30 0.36 
Excessive hunger  11 (3.9) 2 (7.4) 10 (20) 0 (0) 0.01 0.02 
Abnormal perspiring 30 (11) 3 (11) 14 (28) 3 (23) 0.04 0.05 
Tremor 59 (21) 7 (26) 17 (33) 2 (15) 0.30 0.35 
Cold hands or feet 100 (36) 11 (41) 28 (55) 2 (15) 0.05 0.05 
Daytime sleepiness 195 (69) 20 (74) 46 (90) 11 (85) 0.04 0.06 
Joint pain 105 (37) 11 (41) 21 (41) 6 (46) 0.90 0.91 
Sensation of tingling 
and needles 
46 (16) 6 (22) 16 (31) 4 (31) 0.11 0.13 
Weakness, loss of 
consciousness 
12 (4.3) 1 (3.7) 6 (12) 1 (7.7) 0.22 0.22 
Total number of 
symptoms present 
per person, mean 
(SD) 
4.5 (3.2) 5.3 (3.40) 7.0 (3.7) 6.0 (3.8) <0.001 <0.001 
Mean score, mean 
(SD) 
1.6 (0.5) 1.7 (0.5) 2.0 (0.6) 1.9 (0.5) <0.001 <0.001 
a TSCL= The Symptom Check List, 19 variables from 1-5 with higher score indicating more frequent symptoms. 
b Presence of symptoms defined as experience of symptoms at least one day during the last week presented as n 
(%). * Exact Fishers chi squared test for single symptoms and one-way ANOVA for total number of symptoms 
and mean symptom score (mean of 19 items). **Adjusted for age and sex using logistic regression for single 
symptoms and ANCOVA for total number of symptoms and mean symptom score. All p-values adjusted for 
multiple testing using the Benjamini-Hochberg procedure. P-values not reported for vomiting because of low 





Table 4: Self-reported health status (WHOQOL Overall Health, EQ-5D-5L, EQ-VAS), quality of life (WHOQOL Overall QOL) and 



































n 285 27 52 13   
WHOQOL Overall Health b , 
mean(SD) 
3.3 (0.9) 3.3 (0.9) 3.1 (0.9) 2.7 (1.0) 0.04 0.03 
EQ-5D-5L index value c, 
mean(SD) 
0.9 (0.2) 0.9 (0.2) 0.8 (0.2) 0.7 (0.3) 0.004 0.04 
EQ VAS d, mean(SD) 65.0 (21.6) 60.9 ( 24.0) 62.2 (24.5) 56.9 (26.8) 0.45 0.54 
WHOQOL Overall QOLb , 
mean(SD) 
3.5 (0.9) 3.6 (1.0) 3.21 (1.0) 3.1 (0.8) 0.06 0.06 
WHO-5 e, mean(SD) 62.5 (19.0) 65.3 (20.9) 57.9 (22.9) 48.9 (19.6) 0.03 0.02 
*Oneway-ANOVA **Adjusted for age and sex using ANCOVA  
a n=373 for analyses of EQ-5D-5L and EQ VAS.  b 1-5 scale, higher scores indicating better general health or quality of life. 
c EQ-5D-5L index value, 0-1 scale, with higher 
score indicating better health status. d EQ VAS, 0-100 scale, with higher score indicating better self-reported health. e 0–100 scale, higher scores indicating better 
psychological wellbeing 
 
